skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Mostrar Somente
Refinado por: Base de dados/Biblioteca: ScienceDirect remover Base de dados/Biblioteca: Wiley-Blackwell Full Collection 2013 remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Pharmacokinetic interaction between the hepatitis C virus protease inhibitor boceprevir and cyclosporine and tacrolimus in healthy volunteers
Pharmacokinetic interaction between the hepatitis C virus protease inhibitor boceprevir and cyclosporine and tacrolimus in healthy volunteers
Material Type:
Artigo 		Adicionar ao Meu Espaço

Pharmacokinetic interaction between the hepatitis C virus protease inhibitor boceprevir and cyclosporine and tacrolimus in healthy volunteers

Hulskotte, Ellen ; Gupta, Samir ; Xuan, Fengjuan ; van Zutven, Marga ; O'Mara, Edward ; Feng, Hwa-Ping ; Wagner, John ; Butterton, Joan

Hepatology (Baltimore, Md.), 2012-11, Vol.56 (5), p.1622-1630 [Periódico revisado por pares]

Hoboken: Wiley Subscription Services, Inc., A Wiley Company

Texto completo disponível

Citações Citado por
2
An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases
An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases
Material Type:
Artigo 		Adicionar ao Meu Espaço

An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases

Ghany, Marc G. ; Nelson, David R. ; Strader, Doris B. ; Thomas, David L. ; Seeff, Leonard B.

Hepatology (Baltimore, Md.), 2011-10, Vol.54 (4), p.1433-1444 [Periódico revisado por pares]

Hoboken: Wiley Subscription Services, Inc., A Wiley Company

Texto completo disponível

Citações Citado por
3
Naturally occurring dominant resistance mutations to hepatitis C virus protease and polymerase inhibitors in treatment‐naïve patients
Naturally occurring dominant resistance mutations to hepatitis C virus protease and polymerase inhibitors in treatment‐naïve patients
Material Type:
Artigo 		Adicionar ao Meu Espaço

Naturally occurring dominant resistance mutations to hepatitis C virus protease and polymerase inhibitors in treatment‐naïve patients

Kuntzen, Thomas ; Timm, Joerg ; Berical, Andrew ; Lennon, Niall ; Berlin, Aaron M. ; Young, Sarah K. ; Lee, Bongshin ; Heckerman, David ; Carlson, Jonathan ; Reyor, Laura L. ; Kleyman, Marianna ; McMahon, Cory M. ; Birch, Christopher ; Schulze zur Wiesch, Julian ; Ledlie, Timothy ; Koehrsen, Michael ; Kodira, Chinnappa ; Roberts, Andrew D. ; Lauer, Georg M. ; Rosen, Hugo R. ; Bihl, Florian ; Cerny, Andreas ; Spengler, Ulrich ; Liu, Zhimin ; Kim, Arthur Y. ; Xing, Yanming ; Schneidewind, Arne ; Madey, Margaret A. ; Fleckenstein, Jaquelyn F. ; Park, Vicki M. ; Galagan, James E. ; Nusbaum, Chad ; Walker, Bruce D. ; Lake‐Bakaar, Gerond V. ; Daar, Eric S. ; Jacobson, Ira M. ; Gomperts, Edward D. ; Edlin, Brian R. ; Donfield, Sharyne M. ; Chung, Raymond T. ; Talal, Andrew H. ; Marion, Tony ; Birren, Bruce W. ; Henn, Matthew R. ; Allen, Todd M.

Hepatology (Baltimore, Md.), 2008-12, Vol.48 (6), p.1769-1778 [Periódico revisado por pares]

Hoboken: Wiley Subscription Services, Inc., A Wiley Company

Texto completo disponível

Citações Citado por
4
Cost-effectiveness of boceprevir or telaprevir for untreated patients with genotype 1 chronic hepatitis C
Cost-effectiveness of boceprevir or telaprevir for untreated patients with genotype 1 chronic hepatitis C
Material Type:
Artigo 		Adicionar ao Meu Espaço

Cost-effectiveness of boceprevir or telaprevir for untreated patients with genotype 1 chronic hepatitis C

Cammà, Calogero ; Petta, Salvatore ; Enea, Marco ; Bruno, Raffaele ; Bronte, Fabrizio ; Capursi, Vincenza ; Cicchetti, Americo ; Colombo, Giorgio L. ; Di Marco, Vito ; Gasbarrini, Antonio ; Craxì, Antonio

Hepatology (Baltimore, Md.), 2012-09, Vol.56 (3), p.850-860 [Periódico revisado por pares]

Hoboken: Wiley Subscription Services, Inc., A Wiley Company

Texto completo disponível

Citações Citado por
5
Sofosbuvir, Glecaprevir, Pibrentasvir, and Ribavirin as a Rescue Therapy in Difficult‐to‐Treat HCV Patients
Sofosbuvir, Glecaprevir, Pibrentasvir, and Ribavirin as a Rescue Therapy in Difficult‐to‐Treat HCV Patients
Material Type:
Artigo 		Adicionar ao Meu Espaço

Sofosbuvir, Glecaprevir, Pibrentasvir, and Ribavirin as a Rescue Therapy in Difficult‐to‐Treat HCV Patients

Meszaros, Magdalena ; Truchi, Régine ; Ouzan, Denis ; Tran, Albert ; Bourlière, Marc ; Pageaux, Georges‐Philippe

Hepatology (Baltimore, Md.), 2021-10, Vol.74 (4), p.2304-2306 [Periódico revisado por pares]

United States: Wiley Subscription Services, Inc

Texto completo disponível

Citações Citado por
6
A Study of Fasoracetam’s Solid State Forms: A Potential Anti-Alzheimer Pharmaceutical
A Study of Fasoracetam’s Solid State Forms: A Potential Anti-Alzheimer Pharmaceutical
Material Type:
Artigo 		Adicionar ao Meu Espaço

A Study of Fasoracetam’s Solid State Forms: A Potential Anti-Alzheimer Pharmaceutical

Harmsen, Bram ; Robeyns, Koen ; Wouters, Johan ; Leyssens, Tom

Journal of pharmaceutical sciences, 2017-05, Vol.106 (5), p.1317-1321 [Periódico revisado por pares]

United States: Elsevier Inc

Sem texto completo

Citações Citado por
7
Telaprevir, boceprevir, cytochrome P450 and immunosuppressive agents — A potentially lethal cocktail
Telaprevir, boceprevir, cytochrome P450 and immunosuppressive agents — A potentially lethal cocktail
Material Type:
Artigo 		Adicionar ao Meu Espaço

Telaprevir, boceprevir, cytochrome P450 and immunosuppressive agents — A potentially lethal cocktail

Charlton, Michael

Hepatology (Baltimore, Md.), 2011-07, Vol.54 (1), p.3-5 [Periódico revisado por pares]

Hoboken: Wiley Subscription Services, Inc., A Wiley Company

Texto completo disponível

Citações Citado por
8
Anemia during treatment with peginterferon Alfa‐2b/ribavirin and boceprevir: Analysis from the serine protease inhibitor therapy 2 (SPRINT‐2) trial
Anemia during treatment with peginterferon Alfa‐2b/ribavirin and boceprevir: Analysis from the serine protease inhibitor therapy 2 (SPRINT‐2) trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Anemia during treatment with peginterferon Alfa‐2b/ribavirin and boceprevir: Analysis from the serine protease inhibitor therapy 2 (SPRINT‐2) trial

Sulkowski, Mark S. ; Poordad, Fred ; Manns, Michael P. ; Bronowicki, Jean‐Pierre ; Rajender Reddy, K. ; Harrison, Stephen A. ; Afdhal, Nezam H. ; Sings, Heather L. ; Pedicone, Lisa D. ; Koury, Kenneth J. ; Sniukiene, Vilma ; Burroughs, Margaret H. ; Albrecht, Janice K. ; Brass, Clifford A. ; Jacobson, Ira M.

Hepatology (Baltimore, Md.), 2013-03, Vol.57 (3), p.974-984 [Periódico revisado por pares]

Hoboken: Wiley Subscription Services, Inc., A Wiley Company

Texto completo disponível

Citações Citado por
9
RNA‐binding protein SFPQ cooperates with HDAC1 to suppress CD40 transcription in pulmonary adventitial fibroblasts
RNA‐binding protein SFPQ cooperates with HDAC1 to suppress CD40 transcription in pulmonary adventitial fibroblasts
Material Type:
Artigo 		Adicionar ao Meu Espaço

RNA‐binding protein SFPQ cooperates with HDAC1 to suppress CD40 transcription in pulmonary adventitial fibroblasts

Pan, Yan‐Yun ; Yang, Jin‐Xiu ; Mao, Wei ; Wang, Xing‐Xiang

Cell biology international, 2020-01, Vol.44 (1), p.166-176 [Periódico revisado por pares]

England: Wiley Subscription Services, Inc

Texto completo disponível

Citações Citado por
10
Renal impairment is frequent in chronic hepatitis C patients under triple therapy with telaprevir or boceprevir
Renal impairment is frequent in chronic hepatitis C patients under triple therapy with telaprevir or boceprevir
Material Type:
Artigo 		Adicionar ao Meu Espaço

Renal impairment is frequent in chronic hepatitis C patients under triple therapy with telaprevir or boceprevir

Mauss, Stefan ; Hueppe, Dietrich ; Alshuth, Ulrich

Hepatology (Baltimore, Md.), 2014-01, Vol.59 (1), p.46-48 [Periódico revisado por pares]

United States: Wiley Subscription Services, Inc

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Recursos Online (199)

Data de Publicação 

De até
Refinar
  1. Antes de1982  (19)
  2. 1982Até1991  (53)
  3. 1992Até2001  (67)
  4. 2002Até2012  (53)
  5. Após 2012  (67)
  6. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.